Target Price | €60.57 |
Price | €46.58 |
Potential | 30.03% |
Number of Estimates | 19 |
19 Analysts have issued a price target Siemens Healthineers 2026 . The average Siemens Healthineers target price is €60.57. This is 30.03% higher than the current stock price. The highest price target is €75.00 61.01% , the lowest is €50.00 7.34% . | |
A rating was issued by 20 analysts: 18 Analysts recommend Siemens Healthineers to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2026 of 30.03% . Most analysts recommend the Siemens Healthineers stock at Purchase. |
17 Analysts have issued a sales forecast Siemens Healthineers 2025 . The average Siemens Healthineers sales estimate is €23.7b . This is 2.25% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €23.9b 3.19% , the lowest is €23.4b 1.07% .
This results in the following potential growth metrics:
2024 | €22.4b | 3.15% |
---|---|---|
2025 | €23.7b | 5.81% |
2026 | €25.1b | 5.89% |
2027 | €26.6b | 6.15% |
2028 | €28.4b | 6.92% |
2029 | €30.2b | 6.10% |
17 Analysts have issued an Siemens Healthineers EBITDA forecast 2025. The average Siemens Healthineers EBITDA estimate is €4.9b . This is 10.85% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €5.3b 20.02% , the lowest is €4.5b 3.22% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €4.0b | 9.30% |
---|---|---|
2025 | €4.9b | 20.56% |
2026 | €5.4b | 10.42% |
2027 | €5.9b | 10.47% |
2028 | €6.5b | 9.83% |
2029 | €7.0b | 7.84% |
2024 | 18.03% | 5.96% |
---|---|---|
2025 | 20.54% | 13.92% |
2026 | 21.42% | 4.28% |
2027 | 22.29% | 4.06% |
2028 | 22.90% | 2.74% |
2029 | 23.27% | 1.62% |
11 Siemens Healthineers Analysts have issued a net profit forecast 2025. The average Siemens Healthineers net profit estimate is €2.2b . This is 7.66% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.4b 12.56% , the lowest is €2.1b 0.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | €1.9b | 28.69% |
---|---|---|
2025 | €2.2b | 15.81% |
2026 | €2.6b | 16.25% |
2027 | €3.0b | 13.66% |
2028 | €3.4b | 13.17% |
2029 | €3.8b | 12.57% |
2024 | 8.68% | 24.76% |
---|---|---|
2025 | 9.50% | 9.40% |
2026 | 10.44% | 9.89% |
2027 | 11.17% | 6.99% |
2028 | 11.83% | 5.91% |
2029 | 12.55% | 6.09% |
11 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers EPS is €2.01 . This is 8.06% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.10 12.90% , the lowest is €1.85 0.54% .
This results in the following potential growth metrics and future valuations:
2024 | €1.73 | 29.10% |
---|---|---|
2025 | €2.01 | 16.18% |
2026 | €2.33 | 15.92% |
2027 | €2.65 | 13.73% |
2028 | €3.00 | 13.21% |
2029 | €3.38 | 12.67% |
Current | 25.04 | 23.49% |
---|---|---|
2025 | 23.23 | 7.24% |
2026 | 19.98 | 13.99% |
2027 | 17.58 | 12.01% |
2028 | 15.53 | 11.66% |
2029 | 13.80 | 11.14% |
Based on analysts' sales estimates for 2025, the Siemens Healthineers stock is valued at an EV/Sales of 2.81 and an P/S ratio of 2.22 .
This results in the following potential growth metrics and future valuations:
Current | 2.87 | 15.59% |
---|---|---|
2025 | 2.81 | 2.04% |
2026 | 2.66 | 5.56% |
2027 | 2.50 | 5.79% |
2028 | 2.34 | 6.47% |
2029 | 2.20 | 5.75% |
Current | 2.27 | 18.04% |
---|---|---|
2025 | 2.22 | 2.20% |
2026 | 2.10 | 5.56% |
2027 | 1.97 | 5.80% |
2028 | 1.85 | 6.47% |
2029 | 1.74 | 5.76% |
Siemens Healthineers...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
JEFFERIES |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
DZ BANK |
Hold
➜
Hold
|
Unchanged | Mar 24 2025 |
HSBC |
Buy
➜
Hold
|
Downgrade | Mar 23 2025 |
DAY BY DAY |
Sell
➜
Buy
|
Upgrade | Mar 23 2025 |
REDBURN ATLANTIC |
Buy
➜
Buy
|
Unchanged | Mar 21 2025 |
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Feb 27 2025 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Mar 26 2025 |
Unchanged
DZ BANK:
Hold
➜
Hold
|
Mar 24 2025 |
Downgrade
HSBC:
Buy
➜
Hold
|
Mar 23 2025 |
Upgrade
DAY BY DAY:
Sell
➜
Buy
|
Mar 23 2025 |
Unchanged
REDBURN ATLANTIC:
Buy
➜
Buy
|
Mar 21 2025 |
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Feb 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.